Merck Newswire

Comprehensive Real-Time News Feed for Merck .

Results 1 - 20 of 727 in Merck

  1. ETF Securities Expands Equity ETF Lineup With Two More New FundsRead the original story w/Photo

    14 hrs ago | Seeking Alpha

    ETF Securities, the London-based exchange-traded funds issuer known primarily for its lineup of commodities funds, is again adding to its lineup of U.S.-listed equity-based offering with the debuts of the ETFS Diversified-Factor U.S. Large Cap Index Fund and the ETFS Diversified-Factor Developed Europe Index Fund . ETF Securities is partnering with ERI Scientific Beta on the new ETFs.

    Comment?

  2. Celgene, Merck & Co. Prime Examples of Novel Science "Renaissance," Says VCRead the original story w/Photo

    Wednesday | BioSpace

    ... companies, and other approaches you can go after high medical need with new science." Companies that in the past like Merck or Pfizer Inc. ( PFE ) that may have shut down units that weren't necessarily producing results have roared back into the ...

    Comment?

  3. Stockpickers hope to break seven-year skid versus passive funds in 2015Read the original story w/Photo

    Thursday | MSN Money

    That didn't work out: As the benchmark Standard & Poor's 500 Index gained 29.6 percent in its best year since 1997, mutual funds run by stockpickers slightly lagged cheaper index funds. 2014 was also supposed to be the year of the stockpicker as the S&P 500 rose 11.4 percent, until it wasn't.

    Comment?

  4. Pharma Giant Merck & Co. Scoops Up UK Software Firm for Undisclosed AmountRead the original story

    Wednesday | BioSpace

    The German based company, which employs around 39,000 people in 66 countries, will use the CRedit360 system to track environmental, energy and health and safety data across its four major divisions - replacing several existing software solutions that do no longer fulfil Merck Group's requirements. CRedit360's integrated management software will provide an easy and intuitive way to capture and centralise group sustainability data, eliminating error-prone manual data transfers and improving data integrity.

    Comment?

  5. Stockpickers hope to break 7-year skid versus passive funds in 2015Read the original story

    Wednesday | Reuters

    That didn't work out: As the benchmark Standard & Poor's 500 Index gained 29.6 percent in its best year since 1997, mutual funds run by stockpickers slightly lagged cheaper index funds. 2014 was also supposed to be the year of the stockpicker as the S&P 500 rose 11.4 percent, until it wasn't.

    Comment?

  6. Merck & Co. A Holding Of Latest 13F FilersRead the original story w/Photo

    Wednesday Jan 28 | Forbes.com

    We work to find the most relevant and interesting articles about yield stocks to share with Forbes readers. The site is a one-stop source for aggregated data on dividend stocks, including features such as a dividend stock screener, a live dividend feed, an ex-div calendar, and a dividend calculator.

    Comment?

  7. Questionable MMR Data Buried as Measles Outbreak Spurs Need for VaccineRead the original story

    Wednesday Jan 28 | P&T Community

    ... company of falsifying its mumps vaccine test results to reach an efficacy rate of 95%. According to the scientists, Merck added animal antibodies to a blood sample to give the impression of increased antibodies. Specifically, the suit stated: "In an ...

    Comment?

  8. Merck & Co. Kicks Off Its Capacity Advancement Program- CAP In...Read the original story

    Tuesday Jan 27 | BioSpace

    Merck & Co. Kicks Off Its Capacity Advancement Program- CAP In Collaboration With Emirates Diabetes Society - EDS For The First Time In United Arab Emirates Merck supports Diabetes Education and Community Awareness as part of its Capacity Advancement Program in UAE Dubai, UAE, January 28, 2015: Merck, a leading company for top-quality high-tech products in the pharmaceutical, chemical and life-science sectors, in collaboration with Emirates Diabetes Society today announces the start of Merck Capacity Advancement Program in Diabetes education for medical, nursing and pharmacy undergraduates and primary healthcare providers so that ultimately they act as Diabetes ambassadors across the UAE.

    Comment?

  9. Beef Packers Block Plan To Revive Growth-Promoting DrugRead the original story w/Photo

    Tuesday Jan 27 | KQED

    ... suffer. The drug's manufacturer, Merck, has been working on a plan to rehabilitate it. But that effort has stalled. Merck suspended sales of Zilmax in August 2013, after Tyson, a leading beef processor, announced that it would no longer buy cattle ...

    Comment?

  10. White House Budget To Support Biotech RallyRead the original story

    Tuesday Jan 27 | Benzinga

    ... & Co., Inc. (NYSE: MRK ) began their own ventures into antibiotic research though strategic acquisitions in 2014. Merck is set to pay $8.4 billion in order to acquire Cubist, a smaller company whose focus has been on antibiotics. Actavis took a ...

    Comment?

  11. Dow Analyst Moves: MRKRead the original story

    Tuesday Jan 27 | MarketNewsVideo

    The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Merck & Co. is the #12 analyst pick.

    Comment?

  12. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Tuesday Jan 27 | Business Wire

    IKEA Announces Plans to Open a Columbus Store in Summer 2017 as Swedish Retailer Continues to Expand in U.S. and Midwest )--IKEA, the world's leading home furnishings retailer, today announced it is submitting plans to the City of Columbus, Ohio for a store that would increase the Swe... )--FUND db x-trackers Stoxx Global Select Dividend 100 UCITS ETF DEALING DATE 26-Jan-15 NAV PER SHARE EUR28.7946 NUMBER OF SHARES IN ISSUE 21,788,993 CODE )--National Funding has expanded its business to include Broker Services to fund loans secured by independent sales organizations across the country.

    Comment?

  13. TransCelerate BioPharma Welcomes Merck & Co. and Novo Nordisk to its Membership RosterRead the original story

    Tuesday Jan 27 | Freshnews

    ... Actavis, Allergan, Inc., Astellas Pharma Inc., Biogen Idec, Cubist Pharmaceuticals, EMD Serono, Inc. (a subsidiary of Merck KGaA, Darmstadt, Germany), Medgenics, Inc., Merck & Co., Inc., Novo Nordisk A/S, Shionogi & Co., Ltd. and UCB. Membership in ...

    Comment?

  14. Complicated Intra-Abdominal Infections Global Clinical Trials Review, H2, 2014 - New Report AvailableRead the original story

    Tuesday Jan 27 | PR-inside.com

    This report provides elemental information and data relating to the clinical trials on Complicated Intra-Abdominal Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

    Comment?

  15. Asia's Biggest Vaccine Maker a Huge Threat to Merck & Co.Read the original story

    Monday Jan 26 | BioSpace

    Asia's biggest vaccine maker is working on a string of new low-priced offerings that threaten to undercut brands from the world's biggest pharmaceutical companies. Serum Institute of India Ltd., which makes vaccines injected in 65 percent of the world's children, is targeting newer vaccines, including one for the human papillomavirus that could be available in late 2018 and sell at a third of the price of Merck & Co.'

    Comment?

  16. TransCelerate BioPharma Welcomes Merck & Co. And Novo Nordisk A/S To Its Membership RosterRead the original story

    Monday Jan 26 | BioSpace

    ... Actavis, Allergan, Inc., Astellas Pharma Inc., Biogen Idec, Cubist Pharmaceuticals, EMD Serono, Inc. (a subsidiary of Merck KGaA, Darmstadt, Germany), Medgenics, Inc., Merck & Co., Inc., Novo Nordisk A/S, Shionogi & Co., Ltd. and UCB. Membership in ...

    Comment?

  17. Syrzia win may land pharma with more Greek debts, analystRead the original story w/Photo

    Monday Jan 26 | In-PharmaTechnologist.com

    Syriza's election victory may prompt drugmakers already burdened with unpaid Greek bills to rethink their presence in the country according to one analyst. Left-wing anti-austerity party Syriza swept to victory in Greece last night, winning 149 of the 300 seats up for grabs in the country's election.

    Comment?

  18. Cirrhosis Therapeutics Clinical Trials Review H1 2015 Market Research ReportRead the original story

    Monday Jan 26 | Sys-Con Media

    RnRMarketResearch.com adds "Cirrhosis Global Clinical Trials Review, H1, 2015" to its store. The report provides elemental information and data relating to the clinical trials on Cirrhosis.

    Comment?

  19. Merck & Co. Announces Issues Positive Opinion For Investigational...Read the original story

    Sunday Jan 25 | BioSpace

    Merck , known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of the investigational antibiotic SIVEXTRO A for the treatment of acute bacterial skin and skin structure infections in adults. Merck acquired SIVEXTRO as a part of its purchase, through a subsidiary, of Cubist Pharmaceuticals, Inc. The CHMP positive opinion will be reviewed by the European Commission.

    Comment?

  20. Contraceptives Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020Read the original story

    Monday Jan 26 | Sys-Con Media

    Contraceptives are drugs and devices that are used to prevent pregnancy and sexually transmitted infections. Growing awareness about contraceptives and their offered advantage in preventing pregnancy and sexually transmitted infections is the major factor that is driving the contraceptives market.

    Comment?